ondansetron has been researched along with Anterior Circulation Transient Ischemic Attack in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murozono, M | 1 |
| Miyashita, R | 1 |
| Takeda, A | 1 |
| Ynagita, K | 1 |
| Sato, E | 1 |
| Ogiwara, Y | 1 |
1 other study available for ondansetron and Anterior Circulation Transient Ischemic Attack
| Article | Year |
|---|---|
Co-administration of Cyclosporin A and Ondansetron decreases transient local cerebral ischemic injury in the mouse.
Topics: Animals; Cerebrovascular Circulation; Cyclosporine; Disease Models, Animal; Drug Therapy, Combinatio | 2017 |